Toronto, Ontario, Canada Among the most successful fund investment fields, there are Biopharma, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Antios Therapeutics.
The standard case for the fund is to invest in rounds with 7 partakers. The meaningful sponsors for the fund in investment in the same round are Lumira Ventures, Georgia Research Alliance, Fonds de solidaritu00e9 FTQ.
The important activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Day One Investment | - |
| FightMND | Australia, Docklands, Victoria |
| Jiayin Investment | China, Hangzhou, Zhejiang |
| Malakoff Mederic | France, Ile-de-France, Paris |
| SUNTO | China, Guangdong, Shenzhen |
| Techstars Workforce Development Accelerator | - |
| Thien Viet Securities | Cho Lon, Vietnam |
| Valpro Capital | Delhi, India, New Delhi |
| Zee Entertainment Enterprises | India, Maharashtra, Mumbai |
| Zhipu Jishi Xinxi | Beijing, Beijing Shi, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NextPoint Therapeutics | $42M | 14 Feb 2024 | Cambridge, Massachusetts, United States | ||
NextPoint Therapeutics | $80M | 10 Jan 2023 | Cambridge, Massachusetts, United States | ||
Bionaut Labs | $43M | 28 Nov 2022 | Los Angeles, California, United States | ||
DataGrail | $45M | 12 Oct 2022 | San Francisco, California, United States | ||
Radius Agent | 06 Jan 2022 | San Francisco, California, United States | |||
Korro Bio | $116M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
Bionaut Labs | 12 Nov 2021 | Los Angeles, California, United States | |||
Antios Therapeutics | $75M | 03 Nov 2021 | Atlanta, Georgia, United States | ||
CinCor Pharma | $143M | 12 Oct 2021 | Cincinnati, Ohio, United States |
– Turnstone Biologics Corp. announced the successful completion of an $80m Series D financing co-led by PFM Health Sciences and Point72.
– New investors include Eventide Asset Management, Surveyor Capital (a Citadel company), Ridgeback Capital Investments, Takeda Ventures, CaaS Capital, JM Family Enterprises, Inc., Northleaf Capital Partners, 404 Bio and an undisclosed investor.
– The round was joined by existing investors Versant Ventures, OrbiMed, F-Prime Capital, Sectoral Asset Management, Sixty Degree Capital, Brace Pharma Capital and Teralys Capital.
– Proceeds from the financing will be used to advance Turnstone’s pipeline of programs from its oncolytic virus and TIL therapy platforms.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NextPoint Therapeutics | $42M | 14 Feb 2024 | Cambridge, Massachusetts, United States | ||
NextPoint Therapeutics | $80M | 10 Jan 2023 | Cambridge, Massachusetts, United States | ||
Bionaut Labs | $43M | 28 Nov 2022 | Los Angeles, California, United States | ||
DataGrail | $45M | 12 Oct 2022 | San Francisco, California, United States | ||
Radius Agent | 06 Jan 2022 | San Francisco, California, United States | |||
Korro Bio | $116M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
Bionaut Labs | 12 Nov 2021 | Los Angeles, California, United States | |||
Antios Therapeutics | $75M | 03 Nov 2021 | Atlanta, Georgia, United States | ||
CinCor Pharma | $143M | 12 Oct 2021 | Cincinnati, Ohio, United States |
